Research has found the number of infiltrating lymphocytes, especially CD4 and CD8 T cells and dendritic cells, in the tumor immune microenvironment can be used as a prognostic indicator for patients with BC (Li et al., 2021). The gene discussed is CD4; the disease is breast cancer.